Rapport Therapeutics logo

Rapport Therapeutics Share Price (NASDAQ: RAPP)

$17.63

0.83

(4.94%)

Last updated on

Check the interactive Rapport Therapeutics Stock chart to analyse performance

Rapport Therapeutics stock performance

as on August 30, 2025 at 1:29 am IST

  • Today's Low:$16.26
    Today's High:$17.90

    Day's Volatility :9.16%

  • 52 Weeks Low:$6.43
    52 Weeks High:$29.74

    52 Weeks Volatility :78.38%

Rapport Therapeutics Stock Returns

PeriodRapport Therapeutics Inc.Index (Russel 2000)
3 Months
87.55%
0.0%
6 Months
146.57%
0.0%
1 Year
-12.9%
0.0%
3 Years
-15.24%
-4.7%

Rapport Therapeutics Inc. Key Stats

Check Rapport Therapeutics key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$16.8
Open
$17.06
Today's High
$17.9
Today's Low
$16.26
Market Capitalization
$613.2M
Today's Volume
$387.0K
52 Week High
$29.74
52 Week Low
$6.43
Revenue TTM
$0.0
EBITDA
$-100.8M
Earnings Per Share (EPS)
$1.2
PE Ratio
14.0
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-29.42%

Stock Returns calculator for Rapport Therapeutics Stock including INR - Dollar returns

The Rapport Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Rapport Therapeutics investment value today

Current value as on today

₹86,342

Returns

₹13,658

(-13.66%)

Returns from Rapport Therapeutics Stock

₹18,943 (-18.94%)

Dollar Returns*

₹5,284 (+5.28%)

Indian investors sentiment towards Rapport Therapeutics Stock

-88%

Period: Jul 31, 2025 to Aug 30, 2025. Change in 30 Days versus previous period

Search interest for Rapport Therapeutics Stock from India on INDmoney has decreased by -88% in the last 30 days, reflecting a downward trend in search activity.

Analyst Recommendation on Rapport Therapeutics Stock

Rating
Trend

Rapport Therapeutics Share Price Target

What analysts predicted

Upside of 93.99%

Target:

$34.20

Current:

$17.63

Rapport Therapeutics share price target is $34.20, a slight Upside of 93.99% compared to current price of $17.63 as per analysts' prediction.

Rapport Therapeutics Stock Insights

  • Price Movement

    In the last 7 days, RAPP stock has moved up by 19.4%
  • RAPP vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 69.9% return, outperforming this stock by 88.8%

Rapport Therapeutics Technicals Summary

Sell

Neutral

Buy

Rapport Therapeutics is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Rapport Therapeutics Inc. Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Rapport Therapeutics Inc. logo
24.59%
146.57%
-12.9%
-15.24%
-15.24%
Regeneron Pharmaceuticals, Inc. logo
6.48%
-15.2%
-50.31%
-3.3%
-2.01%
Beone Medicines Ltd logo
1.77%
24.81%
62.78%
79.11%
29.69%
Vertex Pharmaceuticals Incorporated logo
-14.45%
-19.13%
-17.84%
34.68%
41.87%
Alnylam Pharmaceuticals, Inc. logo
13.79%
83.28%
75.87%
111.28%
242.25%

About Rapport Therapeutics Inc.

Rapport Therapeutics, Inc., operates as a clinical-stage biopharmaceutical company that focuses on the discovery and development of transformational small molecule medicines for patients suffering from central nervous system (CNS) disorders. Its lead product candidate is receptor associated protein (RAP)-219, an investigational small molecule that is designed to inhibit TARPy8-containing AMPARs with picomolar affinity for the treatment of focal epilepsy and other CNS disorders, including peripheral neuropathic pain and bipolar disorder. The company also develops RAP-199, a TARPy8 targeted molecule with differentiated chemical and pharmacokinetic properties; and nicotinic acetylcholine receptor (nAChR) programs, such as a6 nAChR to treat chronic pain and a9a10 nAChR for the treatment of hearing disorders. The company was formerly known as Precision Neuroscience NewCo, Inc. and changed its name to Rapport Therapeutics, Inc. in October 2022. Rapport Therapeutics, Inc. was incorporated in 2022 and is based in Boston, Massachusetts.
Organization
Rapport Therapeutics
Employees
69
CEO
Mr. Abraham N. Ceesay M.B.A.
Industry
Miscellaneous

Key Management of Rapport Therapeutics Inc.

NameTitle
Dr. Steven M. Paul M.D.
Founder & Independent Chairman
Mr. Abraham N. Ceesay M.B.A.
CEO, President, Treasurer & Director
Dr. Troy A. Ignelzi
Chief Financial Officer
Mr. David Bredt M.D., Ph.D.
Founder & Chief Scientific Officer
Ms. Cheryl Gault
Chief Operating Officer
Ms. Karina Chmielewski
Chief Information Officer & Head of Operations
Ms. Julie DiCarlo
Head of Communications & Investor Relations
Ms. Kathleen A. Wilkinson
Chief People Officer
Mr. Swamy Yeleswaram Ph.D.
Chief Development Officer
Dr. Arnold R. Gammaitoni Pharm.D.
Senior Vice President of Medical Affairs

Important FAQs about investing in RAPP Stock from India :

What is Rapport Therapeutics share price today?

Rapport Therapeutics share price today is $17.63 as on at the close of the market. Rapport Therapeutics share today touched a day high of $17.90 and a low of $16.26.

What is the 52 week high and 52 week low for Rapport Therapeutics share?

Rapport Therapeutics share touched a 52 week high of $29.74 and a 52 week low of $6.43. Rapport Therapeutics stock price today i.e. is closed at $17.63, lower by 40.72% versus the 52 week high.

How to invest in Rapport Therapeutics Stock (RAPP) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Rapport Therapeutics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Rapport Therapeutics Shares that will get you 0.0851 shares as per Rapport Therapeutics share price of $17.63 per share as on August 30, 2025 at 1:29 am IST.

What is the minimum amount required to buy Rapport Therapeutics Stock (RAPP) from India?

Indian investors can start investing in Rapport Therapeutics (RAPP) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Rapport Therapeutics stock (as per the Rupee-Dollar exchange rate as on August 31, 2025). Based on Rapport Therapeutics share’s latest price of $17.63 as on August 30, 2025 at 1:29 am IST, you will get 0.5672 shares of Rapport Therapeutics. Learn more about fractional shares .

What are the returns that Rapport Therapeutics has given to Indian investors in the last 5 years?

Rapport Therapeutics stock has given -15.24% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?